Published Healthcare & Pharmaceuticals Selective Cyp26 Antagonists Cyp26 inhibitor compounds treat diseases such as psoriasis, while avoiding retinoid related side effects By Queen’s University
Published Healthcare & Pharmaceuticals Novel CYP26A1 Inhibitors A series of compounds was synthesized using rational drug-based design. These compounds represent significant improvements over other clinically tested CYP26 antagonists. By Queen’s University
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
